Published in Science · View the paper (DOI)
A team of scientists has engineered a decoy receptor protein that binds to the SARS-CoV-2 virus and blocks infection in human cells. The research found that this decoy receptor is attractive to the virus due to subtle mutations, making it an ideal candidate for neutralizing the virus.
Coverage from 2 institutions